Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers B > Headlines for Bioenvision Inc. > News item |
Elliott Associates reports 5.8% ownership of Bioenvision
By Lisa Kerner
Charlotte, N.C., Aug. 6 - Bioenvision, Inc. investors led by Elliott Associates, LP bought 3,213,063 of the company's shares between June 5 and Aug. 2, priced from $5.45 to $5.97 each.
The purchase gives the reporting persons a 5.8% stake in the New York pharmaceutical company, according to a schedule 13D filing with the Securities and Exchange Commission.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.